Alvotech issues new shares to holders of convertible bonds

Reykjavik, iceland, july 01, 2024 (globe newswire) -- alvotech (nasdaq: alvo), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued new shares to holders of subordinated convertible bonds, originally issued by alvotech on november 16, 2022, and december 20, 2022, with maturity on december 20, 2025 (the “convertible bonds”).
ALVO Ratings Summary
ALVO Quant Ranking